EGFR and head and neck squamous cell carcinoma: Recently, honokiol is reported to be a promising natural compound in overcoming acquired resistance to cetuximab, a monoclonal antibody against EGFR used for treatment of head and neck squamous cell carcinoma and metastatic colorectal cancer [9].